Drug Recalls

Here you'll find every drug recall the FDA has issued, including prescription medications, over-the-counter drugs, compounded pharmacy products, and dietary supplements. We've been tracking these since 2006 and our database updates several times a day so you're always looking at current information.

Drugs get recalled for a number of reasons: contamination during manufacturing, incorrect potency or dosage, failed quality testing (like dissolution or stability tests), sterility problems in injectable products, or labeling and packaging errors that could cause someone to take the wrong dose. If you find a product on this list that you use, please follow the instructions provided by the FDA to take the necessary precautions.

17,529 total recalls
0 this month

Showing 9101–9120 of 17,529 recalls

May 4, 2018· Milbar Laboratories, Inc.

Recalled Item: MD Complete Clarifying Cleanser (Salicylic Acid 2.0%)

The Issue: GMP Deviations

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
May 4, 2018· Milbar Laboratories, Inc.

Recalled Item: Naturmetic SPF 50 Sunscreen (Octinoxate 7.5%

The Issue: GMP Deviations

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
May 4, 2018· Milbar Laboratories, Inc.

Recalled Item: B Prox 10 Anti-blemish Wash

The Issue: Microbial Contamination of Non-sterile Product

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
May 4, 2018· Milbar Laboratories, Inc.

Recalled Item: Solar Defense Sheer Sunscreen Broad Spectrum SPF50 (Octinoxate 7.5%

The Issue: GMP Deviations

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
May 4, 2018· Noven Pharmaceuticals, Inc.

Recalled Item: Minivelle (estradiol transdermal system) 0.1 mg/day

The Issue: Defective Delivery System: no longer meets the specification

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
May 4, 2018· Noven Pharmaceuticals, Inc.

Recalled Item: Minivelle (estradiol transdermal system) 0.0375 mg/day

The Issue: Defective Delivery System: no longer meets the specification

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
May 1, 2018· Mylan Institutional, Inc. (d.b.a. UDL Laboratories)

Recalled Item: Loxapine Capsules

The Issue: GMP Deviations: a recent FDA inspection of the

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
May 1, 2018· Mylan Institutional, Inc. (d.b.a. UDL Laboratories)

Recalled Item: Loxapine Capsules

The Issue: GMP Deviations: a recent FDA inspection of the

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
May 1, 2018· AuroMedics Pharma LLC

Recalled Item: Piperacillin and Tazobactam for Injection

The Issue: Presence of Particulate Matter: confirmed customer report for

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class I — Serious Health HazardTerminated
Refund
May 1, 2018· AuroMedics Pharma LLC

Recalled Item: Ampicillin and Sulbactam for Injection

The Issue: Presence of Particulate Matter: confirmed customer report of

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class I — Serious Health HazardTerminated
Refund
April 30, 2018· Teva Pharmaceuticals USA

Recalled Item: Lidocaine Patch 5% (700 mg)

The Issue: Failed Stability Specifications

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class III — Low RiskTerminated
Refund
April 30, 2018· Mylan Pharmaceuticals Inc.

Recalled Item: PrednisoLONE Sodium Phosphate Orally Disintegrating Tablets 15 mg

The Issue: CGMP Deviations

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
April 30, 2018· Mylan Pharmaceuticals Inc.

Recalled Item: PrednisoLONE Sodium Phosphate Orally Disintegrating Tablets 10 mg

The Issue: CGMP Deviations

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
April 30, 2018· Mylan Pharmaceuticals Inc.

Recalled Item: PrednisoLONE Sodium Phosphate Orally Disintegrating Tablets

The Issue: CGMP Deviations

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
April 27, 2018· Sanofi-Aventis U.S. LLC

Recalled Item: Docetaxel injection concentrate

The Issue: Superpotent drug: over-concentrated vials of Docetaxel injection concentrate

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
April 26, 2018· Sun Pharmaceutical Industries, Inc.

Recalled Item: Riomet (metformin hydrochloride oral solution)

The Issue: Labeling: Not Elsewhere Classified: Sun Pharma has decided

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class III — Low RiskTerminated
Refund
April 26, 2018· Coast Quality Pharmacy LLC

Recalled Item: Macroaggregated albumin (MAA) kit (for the preparation of Tc99m MAA)

The Issue: Sterility Concerns

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
April 24, 2018· Mylan Pharmaceuticals Inc.

Recalled Item: Amlodipine and Benazapril HCL Capsules

The Issue: cGMP Deviations; cleaning process for equipment used to

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
April 24, 2018· Mylan Pharmaceuticals Inc.

Recalled Item: Loxapine Capsules

The Issue: CGMP Deviations

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
April 24, 2018· Mylan Pharmaceuticals Inc.

Recalled Item: Loxapine Capsules

The Issue: CGMP Deviations

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund